Recommendations for dose calculations of lung cancer treatment plans treated with stereotactic ablative body radiotherapy (SABR)

被引:2
|
作者
Devpura, S. [1 ]
Siddiqui, M. S. [1 ]
Chen, D. [1 ]
Liu, D. [1 ]
Li, H. [1 ]
Kumar, S. [1 ]
Gordon, J. [1 ]
Ajlouni, M. [1 ]
Movsas, B. [1 ]
Chetty, I. J. [1 ]
机构
[1] Henry Ford Hlth Syst, Detroit, MI 48202 USA
来源
XVII INTERNATIONAL CONFERENCE ON THE USE OF COMPUTERS IN RADIATION THERAPY (ICCR 2013) | 2014年 / 489卷
关键词
MONTE-CARLO; RADIATION-THERAPY; PHOTON BEAMS; ALGORITHM; VMC;
D O I
10.1088/1742-6596/489/1/012007
中图分类号
O59 [应用物理学];
学科分类号
摘要
The purpose of this study was to systematically evaluate dose distributions computed with 5 different dose algorithms for patients with lung cancers treated using stereotactic ablative body radiotherapy (SABR). Treatment plans for 133 lung cancer patients, initially computed with a 1D-pencil beam (equivalent-path-length, EPL-1D) algorithm, were recalculated with 4 other algorithms commissioned for treatment planning, including 3-D pencil-beam (EPL-3D), anisotropic analytical algorithm (AAA), collapsed cone convolution superposition (CCC), and Monte Carlo (MC). The plan prescription dose was 48 Gy in 4 fractions normalized to the 95% isodose line. Tumors were classified according to location: peripheral tumors surrounded by lung (lung-island, N=39), peripheral tumors attached to the rib-cage or chest wall (lung-wall, N=44), and centrally-located tumors (lung-central, N=50). Relative to the EPL-1D algorithm, PTV D95 and mean dose values computed with the other 4 algorithms were lowest for "lung-island" tumors with smallest field sizes (3-5 cm). On the other hand, the smallest differences were noted for lung-central tumors treated with largest field widths (7-10 cm). Amongst all locations, dose distribution differences were most strongly correlated with tumor size for lung-island tumors. For most cases, convolution/superposition and MC algorithms were in good agreement. Mean lung dose (MLD) values computed with the EPL-1D algorithm were highly correlated with that of the other algorithms (correlation coefficient =0.99). The MLD values were found to be similar to 10% lower for small lung-island tumors with the model-based (conv/superposition and MC) vs. the correction-based (pencil-beam) algorithms with the model-based algorithms predicting greater low dose spread within the lungs. This study suggests that pencil beam algorithms should be avoided for lung SABR planning. For the most challenging cases, small tumors surrounded entirely by lung tissue (lung-island type), a Monte-Carlo-based algorithm may be warranted.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer
    Desai, Neil B.
    Laine, Aaron M.
    Timmerman, Robert D.
    BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1070)
  • [2] A modified formula for dose calculations of stereotactic ablative body radiotherapy for non-small cell lung cancer
    Cao, Yangsen
    Zhu, Xiaofei
    Zhang, Yu
    Yu, Chunshan
    Liu, Yongming
    Sun, Yongjian
    Dai, Zhitao
    Guo, Xueling
    Ju, Xiaoping
    Zhang, Huojun
    MEDICAL DOSIMETRY, 2018, 43 (03) : 207 - 213
  • [3] Stereotactic Ablative Body Radiotherapy for Lung Cancer
    Franks, K. N.
    Jain, P.
    Snee, M. P.
    CLINICAL ONCOLOGY, 2015, 27 (05) : 280 - 289
  • [4] Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia
    Ghandourh, Wsam
    Holloway, Lois
    Batumalai, Vikneswary
    Chlap, Phillip
    Field, Matthew
    Jacob, Susannah
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 34 : 7 - 14
  • [5] Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer
    Abbas, Ghulam
    Danish, Adnan
    Krasna, Mark J.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 553 - +
  • [6] On the dose to a moving target in stereotactic ablative body radiotherapy to lung tumors
    Feygelman, V.
    Dilling, T. J.
    Moros, E. G.
    Zhang, G. G.
    MICRO-MINI & NANO-DOSIMETRY & INNOVATIVE TECHNOLOGIES IN RADIATION THERAPY (MMND&ITRO2016), 2017, 777
  • [7] Effects of reconstruction methods on dose distribution for lung stereotactic body radiotherapy treatment plans
    Yedekci, Yagiz
    Hurmuz, Pervin
    Ozyigit, Gokhan
    RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2023, 62 (01) : 107 - 115
  • [8] The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC)
    Moreno-Olmedo, Elena
    Sabharwal, Ami
    Das, Prantik
    Dallas, Nicola
    Ford, Daniel
    Perna, Carla
    Camilleri, Philip
    CANCERS, 2024, 16 (15)
  • [9] Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
    Ma, Ting Martin
    Lilleby, Oscar
    Lilleby, Wolfgang A.
    Kishan, Amar U.
    CANCERS, 2020, 12 (12) : 1 - 20
  • [10] Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial
    David, Steven
    Tan, Jennifer
    Savas, Peter
    Bressel, Mathias
    Kelly, Dianne
    Foroudi, Farshad
    Loi, Sherene
    Siva, Shankar
    BREAST, 2020, 49 : 55 - 62